Stockholm - Delayed Quote SEK
2cureX AB (publ) (2CUREX.ST)
1.7700
-0.5500
(-23.71%)
At close: May 9 at 5:29:46 PM GMT+2
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Ole Thastrup VD | Co-Founder & Chairman | 300k | -- | 1953 |
| Mr. Dan Honeywell | CEO & Director | -- | -- | -- |
| Ms. Grith Hagel | Co-Founder, VP of Innovation & Director | -- | -- | 1959 |
| Mr. Kenneth Graabek Johansen | Chief Financial Officer | -- | -- | 1976 |
| Mr. Jacob Thastrup | Chief Technology Officer | -- | -- | 1979 |
| Mr. Manuel Fernandez | Director Quality & Regulatory Affairs | -- | -- | -- |
2cureX AB (publ)
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 14
Description
2cureX AB (publ) operates as a medtech company in Europe. The company's principal product is IndiTreat, an IVD test, which helps to predict cancer patient's response and resistance to different drugs and select the appropriate treatment. It is also conducting various clinical programs for IndiTreat for colorectal, ovarian, and pancreatic cancers. The company was incorporated in 2006 and is based in Copenhagen, Denmark.
Corporate Governance
2cureX AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
February 27, 2025 at 10:59 AM UTC
2cureX AB (publ) Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
QUIA.ST Quia Pharma AB (publ)
0.0089
-8.25%
APTA.ST Aptahem AB (publ)
0.8020
+0.25%
NANECH.ST NanoEcho AB
0.1158
+7.22%
DBP-B.ST Double Bond Pharmaceutical Int.
0.3750
-8.31%
SPAGO.ST Spago Nanomedical AB (publ)
0.1860
-2.87%
XSPRAY.ST Xspray Pharma AB (publ)
32.10
-8.29%
DIABIO.ST Diagonal Bio AB (publ)
0.0145
0.00%
NICA.ST Nanologica AB (publ)
1.2550
-0.79%
BIOSGN.ST Biosergen AB
0.4180
+7.46%
ACTI.ST Active Biotech AB (publ)
0.0908
-0.66%